Department of Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
Department of Surgery, Center for Surgery and Health Economics, Philadelphia, Pennsylvania.
JAMA Surg. 2023 Dec 1;158(12):1293-1301. doi: 10.1001/jamasurg.2023.4534.
The benefit of primary care physician (PCP) follow-up as a potential means to reduce readmissions in hospitalized patients has been found in other medical conditions and among patients receiving high-risk surgery. However, little is known about the implications of PCP follow-up for patients with an emergency general surgery (EGS) condition.
To evaluate the association between PCP follow-up and 30-day readmission rates after hospital discharge for an EGS condition.
DESIGN, SETTING, AND PARTICIPANTS: This cohort study used data from the Centers for Medicare & Medicaid Services Master Beneficiary Summary File, Inpatient, Carrier (Part B), and Durable Medical Equipment files for beneficiaries aged 66 years or older who were hospitalized with an EGS condition that was managed operatively or nonoperatively between September 1, 2016, and November 30, 2018. Eligible patients were enrolled in Medicare fee-for-service, admitted through the emergency department with a primary diagnosis of an EGS condition, and received a general surgery consultation during the admission. Data were analyzed between July 11, 2022, and June 5, 2023.
Follow-up with a PCP within 30 days after hospital discharge for the index admission.
The primary outcome was readmission within 30 days after discharge for the index admission. An inverse probability weighted regression model was used to estimate the risk-adjusted association of PCP follow-up with 30-day readmission. The secondary outcome was readmission within 30 days after discharge stratified by treatment type (operative vs nonoperative treatment) during their index admission.
The study included 345 360 Medicare beneficiaries (mean [SD] age, 74.4 [12.0] years; 187 804 females [54.4%]) hospitalized with an EGS condition. Of these, 156 820 patients (45.4%) had a follow-up PCP visit, 108 544 (31.4%) received operative treatment during their index admission, and 236 816 (68.6%) received nonoperative treatment. Overall, 58 253 of 332 874 patients (17.5%) were readmitted within 30 days after discharge for the index admission. After risk adjustment and propensity weighting, patients who had PCP follow-up had 67% lower odds of readmission (adjusted odds ratio [AOR], 0.33; 95% CI, 0.31-0.36) compared with patients without PCP follow-up. After stratifying by treatment type, patients who were treated operatively during their index admission and had subsequent PCP follow-up within 30 days after discharge had 79% reduced odds of readmission (AOR, 0.21; 95% CI, 0.18-0.25); a similar association was seen among patients who were treated nonoperatively (AOR, 0.36; 95% CI, 0.34-0.39). Infectious conditions, heart failure, acute kidney failure, and chronic kidney disease were among the most frequent diagnoses prompting readmission overall and among operative and nonoperative treatment groups.
In this cohort study, follow-up with a PCP within 30 days after discharge for an EGS condition was associated with a significant reduction in the adjusted odds of 30-day readmission. This association was similar for patients who received operative care or nonoperative care during their index admission. In patients aged 66 years or older with an EGS condition, primary care coordination after discharge may be an important tool to reduce readmissions.
重要性:在其他医疗条件和接受高风险手术的患者中,初级保健医生(PCP)随访作为降低住院患者再入院率的潜在手段已得到证实。然而,对于接受急症普通外科(EGS)治疗的患者,PCP 随访的影响知之甚少。
目的:评估 EGS 出院后 30 天内 PCP 随访与再入院率之间的关系。
设计、设置和参与者:本队列研究使用了医疗保险和医疗补助服务中心主受益摘要文件、住院患者、承运人(B 部分)和耐用医疗设备文件的数据,纳入了 2016 年 9 月 1 日至 2018 年 11 月 30 日期间接受手术或非手术治疗的 EGS 疾病的年龄在 66 岁或以上的 Medicare 收费服务受益人。合格患者参加了 Medicare 收费服务,通过急诊部入院,主要诊断为 EGS 疾病,并在入院期间接受了普通外科咨询。数据于 2022 年 7 月 11 日至 2023 年 6 月 5 日进行分析。
暴露:出院后 30 天内与 PCP 随访。
主要结果和措施:主要结局是出院后 30 天内因索引入院再次入院。采用逆概率加权回归模型估计 PCP 随访与 30 天再入院风险调整关联。次要结局是根据治疗类型(手术治疗与非手术治疗)在索引入院期间进行分层的 30 天内再入院。
结果:这项研究纳入了 345360 名 Medicare 受益人(平均[标准差]年龄,74.4[12.0]岁;187804 名女性[54.4%]),患有 EGS 疾病。其中,156820 名患者(45.4%)进行了 PCP 随访,108544 名(31.4%)接受了手术治疗,236816 名(68.6%)接受了非手术治疗。总体而言,332874 名患者中有 58253 名(17.5%)在索引入院后 30 天内再次入院。在风险调整和倾向评分加权后,与未进行 PCP 随访的患者相比,进行 PCP 随访的患者再入院的可能性降低了 67%(调整后的优势比[OR],0.33;95%CI,0.31-0.36)。在按治疗类型分层后,在索引入院期间接受手术治疗且出院后 30 天内进行 PCP 随访的患者,再入院的可能性降低了 79%(OR,0.21;95%CI,0.18-0.25);在接受非手术治疗的患者中也观察到类似的关联(OR,0.36;95%CI,0.34-0.39)。在总体和手术治疗和非手术治疗组中,感染性疾病、心力衰竭、急性肾损伤和慢性肾病是导致再入院的最常见诊断。
结论和相关性:在这项队列研究中,EGS 疾病出院后 30 天内与 PCP 随访与调整后 30 天内再入院的可能性显著降低相关。对于接受手术治疗或非手术治疗的患者,这种关联是相似的。对于年龄在 66 岁或以上患有 EGS 疾病的患者,出院后的初级保健协调可能是降低再入院率的重要工具。